Company news
Genincode Plc (LSE:GENI) news
Genincode Plc news releases on 6ix. Latest, Jan 3, 2023: Approval of California state license
Press releases — page 2
Approval of California state license
January 3, 2023
Issue of Share Options
November 22, 2022
British Medical Journal publication
November 3, 2022
Half-year report
September 27, 2022
Notice of results
September 7, 2022
NHS implementation of Lipid inCode testing
July 26, 2022
Director Appointment
April 6, 2022
Indiana University Medical School collaboration
March 23, 2022
Lipid inCode pilot
March 15, 2022
Confirmation of board appointment
February 21, 2022
Positive results for Lipid inCode in NHS study
February 8, 2022
Proposed independent directorate appointment
January 21, 2022
FDA Pre-Submission for Cardio inCode-SCORE
January 10, 2022
Directorate Change
November 29, 2021
Grant of Share Options and PDMR dealing
September 17, 2021
Positive Thrombo inCode clinical results
July 26, 2021
Admission to trading on AIM & First Day of Dealing
July 22, 2021